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Since the increasing prevalence of carbapenem-resistant Pseudomonas aeruginosa spp., accurate 
detection of metallo-β-lactamase (MBL) such as blaVIM type enzyme producing isolates became very 
important. However, phenotypic MBL detection methods previously reported are not highly sensitive or 
highly specific. This study aimed to evaluate the performance of a modified IMP-lysate test, the double-
disk-synergy-test (DDST) and the combined-disk-test (CDT) for detecting MBL blaVIM gene in P. 
aeruginosa. The reference technique was PCR molecular test. The study used 12 blaVIM2 producer 
isolates, 13 MBL-negative controls which included 4 imipenem-susceptible strains and 9 imipenem-
resistant strains harbouring blaSHV-2a  genes collected from two Tunisian hospitals and P. aeruginosa 
ATCC27853 and P. aeruginosa COL-1 as negative and positive controls respectively. CDT showed 100% 
of sensitivity. The highest level of specificity was shown by IMP-lysate test (76.92%). To evaluate 
efficiencies of methods, the study noted that the highest Youden Index (YI) was shown by IMP-lysate 
method (0.7), followed by DDST (0.6) than CDT (0.2). Since MBL-Etest and PCR were expensive and not 
adaptable for extension use in clinical microbiology laboratories, a modified IMP-lysate MBL hydrolytic 
activity can be chosen by laboratories with limited resources as an inexpensive, simple, and accurate 
test to detect . P. aeruginosa producing blaVIM  enzyme. 
 





The infections caused by multidrug-resistant  
Pseudomonas aeruginosa strains are becoming 
increasingly prevalent and now constitute a serious threat 
to public health worldwide (Oliver et al., 2015; Kaye and 
Pogue, 2015). Due to their stability against most β-
lactamases, carbapenems such as imipenem have been 
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the drug of choice for treatment of infections caused by 
multidrug resistant  P. aeruginosa. Nevertheless, the first 
isolate of P. aeruginosa with transferable imipenem 
resistance due to metallo-β-lactamase (MBL) production 
was reported in Japan in 1991 (Watanabe et al., 1991). 
Since then, it has been described from various parts of 
the world (Aubron et al., 2005; Mazzariol et al., 2011; 
Viedma et al., 2012;Sardelic et al., 2012) including Africa 
(Pitout et al., 2008; Jacobson et al., 2012; Touati et al., 
2013) and Tunisia (Mansour et al., 2009; Hammami et 
al., 2010; Hammami et al., 2011; Ktari et al., 2011).  
Treatment of infectious diseases caused by the 
carbapenem-resistant P. aeruginosa is becoming more 
challenging with each passing year. It have been 
associated with increased mortality and costs due to 
prolonged hospitalization and prolonged treatment with 
antibiotics (Liu et al., 2015). MBL producing isolates have 
an ability to spread and to hydrolyse virtually all β-lactam 
agents except monobactam (Maltezou, 2009). Detection 
of this resistance-phenotype by routine laboratories is 
essential to initiate adequate therapy and to implement 
proper infection control practices. However, no 
standardized phenotypic method is available, and 
previously reported phenotypic combined disk tests, are 
not highly sensitive or highly specific for the detection of 
MBL in P. aeruginosa (Peter et al., 2014). The most used 
phenotypic screening methods in clinical microbiology 
laboratories are double-disk-synergy-test (DDST), 
combined-disk-test (CDT) (Lee et al., 2001; Yong et al., 
2002; Lee et al., 2003) and the current most widely 
accepted technique; the MBL E-test ( AB Biodisk, Solna, 
Sweeden) (Tan et al., 2008). All of these phenotypic tests 
are based upon the ability of chelating agents, EDTA and 
thiol-based compounds, to inhibit the MBL activity 
(Andrade et al., 2007).  
A big concern with using these methods is the direct 
bactericidal effect of EDTA on the test strain (Conejo et 
al., 2003; Tan et al., 2008) . To circumvent this problem, 
Tan et al. (2008) proposed an IMP-lysate assay that 
provides a simple, inexpensive  and reproducible 
functional screen for MBL-producing P. aeruginosa (Tan 
et al., 2008). The IMP-lysate assay allows EDTA to 
interact with the carbapenamase in vitro, effectively 
reducing the concentration of EDTA that interacts with 
the growth of the indicator strain. However, the IMP-
lysate test requires specific equipment, such as microcon 
concentration device (Millipore Bedford, MA) to 
concentrate the lysate which is not available in most 
laboratories. So, the study propose a modification in the 
technique (the study removed the lysate-concentration 
step with the microcon device, and the study incubated 
lysate solution with imipenem and EDTA before 
depositing it on the plate.) without reducing confidence of 
the assay.  The aim of this study was to compare the 
performance of this modified IMP-lysate test, the DDST 
and the CDT for detecting MBL blaVIM gene in P. 
aeruginosa by referring to the molecular test; the PCR. 








The P. aeruginosa strains used in this study were isolated from 
clinical specimens collected from separate patients hospitalized in 
different medical and surgical wards at Fattouma Bourguiba 
Hospital in Monastir, Tunisia and Tahar Sfar Hospital in Mahdia, 
Tunisia on variable periods of times (Table 1). Identification of the 
isolates to the species level was performed by Api 20 NE 
(Biomerieux, France) and by using matrix-assisted laser 
desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF 
MS) (AutoflexTM; Bruker Daltonics, Bremen, Germany) with the 
Flex control software (Bruker Daltonics) (Seng et al., 2009). A total 
of 12 blaVIM2 producer isolates were screened. MBL-negative 
controls included 4 imipenem-susceptible strains and 9 imipenem-
resistant strains harbouring blaSHV-2a  genes. BlaVIM2  and blaSHV-2a  
genes were detected by PCR. Susceptibilities of stains of 
antimicrobials were performed by the disk diffusion method in 
Mueller Hinton agar (Bio-Rad, Marnes-la-Coquette, France) 
according to the guidelines of the Clinical and Laboratory Standards 
Institute (CLSI, 2014). Two control strains were used; P. aeruginosa 
ATCC27853 as negative control (NC) and P. aeruginosa COL-1 
carrying the bla VIM2 gene as positive control.  
 
 
Combined disk tests (CDT) (method A) 
 
Test organisms were inoculated onto plates of Mueller Hinton 
according to the guidelines of the CLSI. Two IMP (10 µg) disks 
(Bio-Rad, Marnes-la-Coquette, France) were placed in an agar 
plate, and 10 µl of a 0.5 M EDTA solution (pH8) was added to one 
of the IMP disks. After incubation overnight at 37°C, the inhibition 
zones of the IMP disks with and without EDTA were compared. A ≥ 
7 mm increase in the zone diameter for IMP in the presence of 
EDTA was interpreted as a positive test result. 
 
 
Double disk synergy tests (DDST) (method B) 
 
Tests organisms were inoculated onto plates of Mueller-Hinton agar 
as described for the standard disk diffusion test (CLSI). An IMP (10 
µg) disk was placed 20 mm (center to center) from a blank disk 
containing 5 µl of 0.5 M EDTA (pH 8). Enhancement of the zone of 
inhibition in the area between the two disks was considered positive 





DNA template preparation was performed as followed. The 
organisms were cultured on blood agar plate (90 mm diameter) and 
incubated for 24 h at 37°C. Half of the overnight culture was 
inoculated into 600 µl of distilled water and vortexed. The cells were 
lysed by heating them at 100°C for 10 min and cellular debris was 
removed by centrifugation at 13000 r/min for 10 min. The 
superntent was used as a source of template for amplification. 
Standard PCR analysis was used for detection of VIM MBL and 
SHV Extended-spectrum β-lactamases (ESBL) genes. The specific 
primers used were: VIM-F: 5’-TGGTCTACATGACCGCGTCT3-3’, 
VIM-R: 5’CGACTGAGCGATTTGTGTG-3’, SHV-F: 5’-
TTTATGGCGTTACCTTTGACC-3’and SHV-R: 5’-
ATTTGTCGCTTCTTTACTCGC-3’ (Yagi et al., 2000). Total 
bacterial DNA was purified with QUIAGEN Kit. Cycling parameters 
of standard PCR were as follows: an initial denaturation step for 15 
min at 95°C, 35 cycles of 1 min at 95°C, 50s at 55°C and 1min at 
72°C and a final incubation step for 7 min at 72°C. Positive PCR 
products were sequenced using BigDye®  terminator  chemistry  on  








Date of isolation 
Site of location 
 Phenotypic screening   Molecular screening 
Day/ Month/ Year  Method A Method B Method C  VIMPCR SHV 2a PCR 
Ps 27 11/13/2007 ICU  Positive  Negative Positive  Positive Positive 
Ps 30 6/7/2008 ICU  Positive Positive Negative  Positive Negative 
Ps 44 10/18/2008 ICU  Positive Positive Positive  Positive Negative 
Ps 48 12/12/2008 S  Positive Positive Positive  Positive Positive 
Ps 62 10/16/2009 S  Positive Positive Positive  Positive Positive 
Ps 63 10/16/2009 ICU  Positive Positive Positive  Positive Positive 
Ps 64 10/17/2009 ICU  Positive Positive Positive  Positive Positive 
Ps 65 10/22/2009 NN  Positive Positive Positive  Positive Positive 
Ps 66 5/11/2011 ENT  Positive Positive Positive  Positive Positive 
Ps 67 5/15/2011 Or  Positive Positive Positive  Positive Positive 
Ps 69 8/13/2008 ICU  Positive Positive Positive  Positive Positive 
Ps 70 8/18/2008 ICU  Positive Positive Positive  Positive Positive 
Ps 22 7/30/2005 ICU  Negative Negative Positive  Negative Positive 
Ps 28 6/4/2008 U  Positive Negative Negative  Negative Positive 
Ps 35 8/25/2008 ICU  Negative  Negative Negative  Negative Positive 
Ps 50 1/23/2009 PNE  Negative Negative Negative  Negative Positive 
Ps 6 12/3/2004 ICU  Positive Positive Negative  Negative Positive 
Ps 11 1/5/2005 ICU  Positive Positive Negative  Negative Positive 
Ps 17 7/4/2005 ID  Positive Negative Negative  Negative Positive 
Ps 20 7/23/2005 ICU  Positive Negative Negative  Negative Positive 
Ps21 7/24/2005 ICU  Positive Negative Positive  Negative Positive 
Ps24 3/28/2006 ICU  Positive Negative Negative  Negative Positive 
Ps29 6/7/2008 ICU  Positive Positive Negative  Negative Positive 
Ps31 6/17/2008 ICU  Positive Negative Negative  Negative Positive 
Ps38 9/6/2008 ICU  Positive Positive Positive  Negative Positive 
PsCOL1 - -  Positive Positive Positive  Positive Negative 
PsATCC27853 - -  Negative Negative Negative  Negative Negative 
 
Ps, strains from Monastir hospital; Ps, strains from Mahdia hospital; ENT, ear,nose and throat; ICU, intensive care unit; NN, neonatal; S, 




an automated ABI 3730 sequencer (PE Applied Biosystems, Foster 
City, CA).  
 
 
MBL hydrolytic activity test (method C) 
 
Test organisms were inoculated onto blood agar plate (90 mm 
diameter) and incubated overnight at 37°C. Half of plate was 
resuspended in 1.5 ml sodium phosphate buffer (pH 7).  The cells 
were subsequently lysed by cycling between (-20°C) and room 
temperature (RT) and a vortex (30 s) for a total of five times. The 
lysed cells were separated from the other debris by centrifugation 
(10 min, 3.200xg, 4°C) and filtration through a 0.22 µm syringe filter 
(Minisart, Sartorius Stedim Biotech, Goettingen, German). About 1 
ml of filtrate was recuperated each time. Instead of concentrating 
the filtrate through a microcon device as described by Tan et al. 
(2008), it was divided equally into two tubes, one of which 
contained 25 µl of 0.5 M EDTA at pH 8. The two samples were 
incubated with 10 µg imipenem per ml for 20 min at 37°C and then 
15 µl from each tube was transferred into 8 mm blank disks (spaced 
by 6 cm) in Mueller Hinton agar plates with indicator isolate 
Escherichia coli ATCC 25922 spread on the surface. On the same 
plate the  study  tested  P. aeruginosa  ATCC27853  (harboring  no 
resistance mechanism) as a negative control and a blank disk with 
15 µl of 10 µg imipenem per milliliter solution. The diameter of 
inhibition zones were measured after overnight incubation at 37°C.  
The IMP-lysate MBL hydrolytic activity assay was confirmed by 
comparing the sizes of zone inhibitions for three disks; the lysate-
IMP disk impregnated with lysates from P. aeruginosa strain and 
IMP, the lysate-IMP-EDTA disk  with the same lysates incubated 
with IMP and EDTA and the third IMP disk  with imipenem solution. 
Negative and positive controls must be tested each time. The 
inhibition zone from the disk (IMP) provided a reference for 
comparison; it was about 20 mm (data not shown). The diminution 
of inhibition zone around lysate-IMP disk, compared to the IMP 
disk, proved the hydrolysis of IMP by the lysate solution. The 
increase of the zone around the lysate-IMP-EDTA disk compared to 
the lysate-IMP disk proved that the enzyme hydrolysing IMP was 





The Youden's Index (YI) 
 
The YI is the difference between the true positive rate and the  false 






Figure 1. Results for IMP-lysate MBL hydrolytic activity test using disk 1 
with lysates from P.aeruginosa COL-1 strain incubated with imipenem 
(IMP) at 10 µg per ml, disk 2 with the same lysates incubated with IMP 
and EDTA (0.5 M), disk 3 negative control with lysates from P. 





positive rate. It is a commonly used measure of overall diagnostic 
effectiveness. This index ranges between 0 and 1, with values 
close to 1 indicating that the biomarker’s effectiveness is relatively 
large and values close to 0 indicating limited effectiveness 





The strains used in this study were unrelated; they were 
collected from two different hospitals, different medical 
and surgical wards, and at different time periods (Table 
1). The positive control sample showed with method C no 
inhibition zone around disk (lysate-IMP) and 15 mm 
inhibition zone around disk (lysate-IMP-EDTA) (Figure 1). 
P. aeruginosa ATCC27853 sample (harbouring no 
resistance mechanism) showed, under the study 
experimental conditions, 16.87±1.76 inhibition zone 
around the disk (lysate-IMP). 
Several tests were carried out on the negative control 
strain (P. aeruginosa ATCC27853). The lysate-IMP disk 
showed no upper than 5 mm decrease compared to the 
IMP disk, which represents the upper bound of MBL-
negative strain and obviously the lower bound of MBL-
positive strain. In fact, a decrease in the inhibition zone of 
>5 mm represents a strong argument for judging a 
positive strain by this assay. Disks impregnated with 
EDTA (0.5M) alone and lysate alone showed no inhibition 
zone with the indicator strain (Figure1). 
Method C was compared to the two phenotypic 
methods considered in this study (method A and method 
B) and to the molecular method (PCR) as a reference 
method. Among the three phenotypic methods 
considered in this study, method A showed 100% of 
sensitivity. Method B and method C showed 91.66% of 
sensitivity. The highest level of specificity was shown by 
method C (76.92%), followed by method B (69.23%) than 
method A (23.07%) (Table 1). To evaluate efficiencies of 
methods, the study noted that the highest Youden Index 
(YI) was shown by method C (0.7), followed by method B 





There is an urgent need for an early detection of MBL-
producing organisms for their prevention of their inter and 
intra hospital dissemination. Currently, the most widely 
accepted standardized MBL functional screen is the MBL 
E-test. However, this method suffers from high cost and 
unavailability of E-test strips. Both CDT and DDST have 
been reported to be reliable in screening for MBL 





















been reported that CDT and DDST were simple, 
inexpensive phenotypic resources for detection of MBL 
that could be easily incorporated into the routines of 
clinical laboratories. In Tunisian clinical laboratories, for 
its high cost, the MBL E-test is not frequently used. 
Generally this test is used for research purposes and not 
for routine screening of MBL. 
Although, MBL E-test has been evaluated to be a 
sensitive method for detection of MBL production in P. 
aeruginosa (Walsh et al., 2002). Qu et al. (2009) reported 
that several MBL-producing strains could not be detected 
by the MBL E-test.  Several studies have been interested 
in evaluation and comparison of phenotypic tests (Yan et 
al., 2004; Picao et al., 2008; Qu et al., 2009). Variable 
results have been reported. Yan et al. (2004) found that 
the DDST was most sensitive for all bacterial species 
tested (Yan et al., 2004). However, one of the major 
disadvantages of the DDST is the subjective 
interpretation of results that depends upon the 
technician’s expertise to discriminate true synergism from 
the intersection of inhibition zones (Picao et al., 2008; Qu 
et al., 2009). Other studies evaluated the CDT as most 
sensitive method (Berges et al., 2007; Picao et al., 2008). 
In this study, DDST was evaluated as more sensitive 
than CDT. Thus, it has been suggested that the selection 
of the best MBL screening method should be based on 
the isolated species, the local prevalence of MBL 
producers, and the ability of specialized technicians to 
correctly interpret MBL inhibition (Yan et al., 2004; Picao 
et al., 2008). 
False detection of MBL in P. aeruginosa by E-test, CDT 
and DDST depend on EDTA susceptibility (Chu et al., 
2005). It is known that EDTA may increase bacterial cell 
wall permeability and so it can increase the susceptibility 
of P. aeruginosa to various antimicrobials, including IMP 
(Ayres et al., 1999). Tan et al. (2008) proposed an IMP-
lysate MBL assay that overcomes the major 
disadvantage of the three phenotypic methods; the direct 
bactericidal EDTA effect on the test strain (Tan et al., 
2008). It provides a simple, inexpensive and reproducible 
functional screen for MBL-producing P. aeruginosa. 
However, that technique requires special equipment, 
specifically the Microcon Device. Due to the cost and the 
scarcity of the device, it is typically not available in 
laboratories.  Thus, the study modified the technique to 
adapt it to laboratory’s conditions. After the elimination of 
the step of enzyme-concentration from the original 
protocol, screening of MBL blaVIM producing P. 
aeruginosa is still simple and easy. Importantly, EDTA 
still has little effect on the indicator strain.  
In this study, method C showed 91.66% of sensitivity 
and 76.92% of specificity, and referring to Youden test, 










adaptable for extension use in clinical microbiology 
laboratories, a modified IMP-lysate MBL hydrolytic 
activity can be chosen by laboratories with limited 
resources as an inexpensive, simple, and accurate test to 
detect P. aeruginosa producing  blaVIM type enzyme. 
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